GNAL

G protein subunit alpha L, the group of G protein subunits alpha, group s

Basic information

Region (hg38): 18:11689264-11885685

Links

ENSG00000141404NCBI:2774OMIM:139312HGNC:4388Uniprot:P38405AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • dystonia 25 (Strong), mode of inheritance: AD
  • dystonia 25 (Strong), mode of inheritance: AD
  • dystonia 25 (Supportive), mode of inheritance: AD
  • dystonia 25 (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Dystonia 25ADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic23222958

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GNAL gene.

  • Dystonic_disorder (112 variants)
  • not_provided (72 variants)
  • not_specified (30 variants)
  • Inborn_genetic_diseases (17 variants)
  • Dystonia_25 (17 variants)
  • GNAL-related_disorder (13 variants)
  • Limb_dystonia (1 variants)
  • Dysarthria (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GNAL gene is commonly pathogenic or not. These statistics are base on transcript: NM_000182978.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
6
clinvar
24
clinvar
7
clinvar
37
missense
3
clinvar
4
clinvar
60
clinvar
3
clinvar
70
nonsense
3
clinvar
2
clinvar
5
start loss
0
frameshift
4
clinvar
4
splice donor/acceptor (+/-2bp)
2
clinvar
1
clinvar
3
Total 10 8 67 27 7

Highest pathogenic variant AF is 0.00000209156

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GNALprotein_codingprotein_codingENST00000334049 12196730
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9980.00171125048011250490.00000400
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.34872290.3800.00001272995
Missense in Polyphen23123.550.186161430
Synonymous0.4668388.60.9370.00000541861
Loss of Function4.25123.00.04350.00000121276

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004620.0000462
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Guanine nucleotide-binding proteins (G proteins) are involved as modulators or transducers in various transmembrane signaling systems. G(olf) alpha mediates signal transduction within the olfactory neuroepithelium and the basal ganglia. May be involved in some aspect of visual transduction, and in mediating the effect of one or more hormones/neurotransmitters.;
Pathway
Dopaminergic synapse - Homo sapiens (human);Amoebiasis - Homo sapiens (human);Chagas disease (American trypanosomiasis) - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Parkinson,s disease - Homo sapiens (human);Olfactory transduction - Homo sapiens (human);G Protein Signaling Pathways;Signaling by GPCR;Signal Transduction;Olfactory Signaling Pathway;G alpha (s) signalling events;Neuronal System;Adenylate cyclase inhibitory pathway;Inhibition of adenylate cyclase pathway;Activation of GABAB receptors;GABA B receptor activation;Rapid glucocorticoid signaling;GABA receptor activation;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;Adenylate cyclase activating pathway;G-protein mediated events;Opioid Signalling;G alpha (i) signalling events;GPCR downstream signalling;LPA4-mediated signaling events;Plasma membrane estrogen receptor signaling;Endothelins (Consensus)

Recessive Scores

pRec
0.189

Intolerance Scores

loftool
0.0256
rvis_EVS
-0.3
rvis_percentile_EVS
32.62

Haploinsufficiency Scores

pHI
0.370
hipred
Y
hipred_score
0.792
ghis
0.572

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.743

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gnal
Phenotype
taste/olfaction phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
signal transduction;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;sensory perception of smell
Cellular component
heterotrimeric G-protein complex;plasma membrane;extracellular exosome
Molecular function
G protein-coupled receptor binding;GTPase activity;GTP binding;G-protein beta/gamma-subunit complex binding;metal ion binding